Cargando…
Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments
Diabetes mellitus leads to increased Advanced Glycation End Products (AGE) production, which has been associated with secondary diabetic complications. Type 1 diabetic patients undergoing pancreas-kidney transplantation (SPKT) can restore normoglycemia and renal function, eventually decreasing AGE a...
Autores principales: | Martins, La Salete, Oliveira, José C., Vizcaíno, José Ramón, Fonseca, Isabel, Gouveia, Carlos, Silva, Donzília, Henriques, António C., Noronha, Irene L., Rodrigues, Anabela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736383/ https://www.ncbi.nlm.nih.gov/pubmed/26881017 http://dx.doi.org/10.1155/2016/2189582 |
Ejemplares similares
-
Fluorescent Advanced Glycation End Products and Their Soluble Receptor: The Birth of New Plasmatic Biomarkers for Risk Stratification of Acute Coronary Syndrome
por: Raposeiras-Roubín, Sergio, et al.
Publicado: (2013) -
Alterations in postmenopausal plasmatic lipidome
por: Nogueira, Iara Antonia Lustosa, et al.
Publicado: (2018) -
Plasmatic Soluble Receptor for Advanced Glycation End Products as a New Oxidative Stress Biomarker in Patients with Prosthetic-Joint-Associated Infections?
por: Massaccesi, Luca, et al.
Publicado: (2017) -
Posttransplant Allosensitization in Low Immunological Risk Kidney and Kidney-Pancreas Graft Recipients
por: Malheiro, Jorge, et al.
Publicado: (2014) -
Plasmatic markers in hemorrhagic stroke
por: Marginean, IC, et al.
Publicado: (2011)